E.g., 07/17/2024
E.g., 07/17/2024

Office of The French Consul General to visit bioMérieux’s St. Louis headquarters in recognition of leadership in diagnostics 

14 April, 2015

The Consul General of France in Chicago, Vincent Floréani, and Honorary Consul General of France in St. Louis, James F. Mauzé, Jr., are scheduled to visit bioMérieux’s St. Louis facility April 14, 2015.

bioMérieux Educates and Engages Future Microbiologists at the Triangle SciTech Expo

10 April, 2015

bioMérieux is working to draw new talent into the field by creating a fun and educational exhibit at the Triangle SciTech Expo for the second year in a row.

USDA adds bioMérieux TEMPO® System to Microbiology Laboratory Guidebook, the Standard-Setting Guideline for Food-Safety Testing in the U.S.

19 March, 2015

TEMPO®’s automated food quality testing will help improve food safety nationwide

bioMérieux - 2014 Financial Results

11 March, 2015

Solid growth in sales: Up 8.7%, including BioFire and at constant exchange rates Up 3.8%, at constant exchange rates and scope of consolidation

bioMérieux to present the latest pharmaceutical monitoring technology, Labguard® 3D, at local Technology conference

09 March, 2015

Durham, NC – March 10, 2014 - bioMérieux Industry, a bioMérieux unit dedicated to industrial application diagnostics, will be present as a corporate partner and exhibitor at the ISPE Carolina-South Atlantic Chapter’s 22nd Annual Life Sciences Technology Conference.

BioFire Receives FDA Clearance for the FilmArray® 2.0 System

26 February, 2015

New system delivers higher throughput, single database management and minimized footprint

Visiting bioMérieux’s North American Headquarters in Durham, French Consul General Recognizes bioMérieux U.S. Leadership in Rapid Identification of Infectious Diseases

11 February, 2015

French Consul General Denis Barbet, accompanied by the new scientific, cultural, and press attachés, Anne Corval, Alexandre Durand, and Heather Clavé, spent the morning Wednesday, February 4, at the North American headquarters of bioMérieux in Durham, North Carolina.

BioFire Defense, a bioMérieux Company, Receives Prestigious Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola Test

10 February, 2015

BioFire Defense, LLC is proud to announce that it is the recipient of the Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola test. The New Product Innovation Award is given to companies that display strong overall performance in the development and market of an innovative new product, including adherence to U.S. Food and Drug Administration (FDA) criteria for Emergency Use Authorization (EUA)* and design of a product that addresses unmet needs.

bioMérieux’s business review for the year ended December 31, 2014

22 January, 2015

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2014.

bioMérieux and Astute Medical agreement to develop and market NEPHROCHECK® Test for VIDAS®

22 January, 2015

bioMérieux and Astute Medical sign a global agreement to develop and market NEPHROCHECK® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury

Pioneering Diagnostics